Herman Verrelst is a seasoned executive and serial entrepreneur with a strong international track-record in founding and managing innovative technology companies in life sciences and diagnostics. He currently is chief executive officer of Biocartis, a molecular diagnostics (MDx) company providing near-patient oncology testing solutions based on its proprietary MDx IdyllaTM platform. Prior to joining Biocartis, Herman Verrelst held the position of vice president and general manager of the genomics and clinical applications division of Agilent Technologies, a global leader in life sciences, diagnostics and applied chemical markets. Mr. Verrelst joined Agilent following Agilent's acquisition of Cartagenia, a spin-off of Katholieke Universiteit Leuven (Belgium) focused on software solutions for clinical genetics and molecular oncology, of which Herman Verrelst was CEO and founder. Prior to that, Herman Verrelst was CEO of medical imaging company Medicim as well as founder and CEO of AI-based data analytics company DATA4s.
Get in touch: